Shinichiro Okamoto

7PUBLICATIONS
68CO-AUTHORS
Medical infection agents (incl. prions)Cancer therapy (excl. chemotherapy and radiation therapy)Haematological tumoursPredictive and prognostic markersApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (7)

|Sep 02, 2025
Identification of a CD138-Negative Therapy-Resistant Subpopulation in Multiple Myeloma with Vulnerability to Splicing Factor Inhibition.

Takahiro Kamiya, Masahiko Ajiro, Motohiko Oshima

|May 29, 2025
Efficacy of Total-Body Irradiation-based Intensified Myeloablative Regimens for Acute Leukemia-An International Collaborative Study.

Yasuyuki Arai, Ruta Brazauskas, Naya He

|Dec 15, 2023
Cord blood transplantation for adult mature lymphoid neoplasms in Europe and Japan.

Mizuki Watanabe, Junya Kanda, Fernanda Volt

|Dec 14, 2022
Negative E-cadherin expression on bone marrow myeloma cell membranes is associated with extramedullary disease.

Maki Hirao, Kohei Yamazaki, Kentaro Watanabe

|Sep 23, 2022
Production and nonclinical evaluation of an autologous iPSC-derived platelet product for the iPLAT1 clinical trial.

Naoshi Sugimoto, Sou Nakamura, Shin Shimizu

|Sep 16, 2022
iPLAT1: the first-in-human clinical trial of iPSC-derived platelets as a phase 1 autologous transfusion study.

Naoshi Sugimoto, Junya Kanda, Sou Nakamura

Pageof 2

Frequent Collaborators

4 joint publications

Junya Kanda

2 joint publications

Yasuyuki Arai

2 joint publications

Akifumi Takaori-Kondo

2 joint publications

Masayuki Nogawa